Related Experiment Videos
Notch signaling in cancer
Eric J Allenspach1, Ivan Maillard, Jon C Aster
1Departments of Pathology and Laboratory Medicine, Institute for Medicine and Engineering, Abramson Family Cancer Research Institute, University of Pennsylvania, 421 Curie Boulevard, Philadelphia, PA 19104, USA.
Cancer Biology & Therapy
|December 24, 2002
Summary
Aberrant Notch signaling, crucial for normal development, can contribute to cancer through disrupted cell growth and survival. This review explores Notch
Area of Science:
- Molecular Biology
- Developmental Biology
- Oncology
Background:
- Notch signaling regulates cell differentiation, survival, and proliferation during development.
- Dysregulation of these processes is fundamental to cancer development.
- Aberrant Notch signaling has been implicated in various human neoplasms.
Purpose of the Study:
- To review recent studies linking aberrant Notch signaling with cancer.
- To discuss mechanisms by which Notch signaling influences cellular transformation.
- To explore potential therapeutic targets within the Notch pathway.
Main Methods:
- Literature review of recent studies on Notch signaling and cancer.
- Analysis of mechanisms of Notch-mediated cellular transformation.
- Identification and discussion of therapeutic targets in the Notch pathway.
Main Results:
- Notch signaling's role in tumorigenesis was first identified in T-cell acute lymphoblastic leukemia (T-ALL).
- Aberrant Notch signaling is implicated in a wide spectrum of human cancers.
- Specific mechanisms linking Notch pathway dysregulation to cancer are being elucidated.
Conclusions:
- Aberrant Notch signaling is a significant factor in the development of various cancers.
- Understanding Notch pathway dysregulation offers opportunities for novel cancer therapies.
- Targeting the Notch pathway presents a promising therapeutic strategy for cancer treatment.